Abiopharma

Change in holdings of interested parties/officers - Isras Holdings Ltd.

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: DISCLOSURE IN INTEREST OF DIRECTOR - WEE KENG NEO LYNDA

Ocugen to Participate in Upcoming August Investor Conferences

GCL Announces Fiscal Year 2026 Financial Results

Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026

Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab

Balchem Corporation Reports Second Quarter 2026 Financial Results

Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates

Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation

INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th